Arrowhead Pharmaceuticals, Inc. (ARWR) vs Bruker Corporation (BRKRP)
A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Bruker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARWR
Arrowhead Pharmaceuticals, Inc.
$60.83HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
BRKRP
Bruker Corporation
$437.31HealthcareDelayed quote: Oct 6, 2026, 10:46 AM EDT
Total return — ARWR vs BRKRP
growth of $100 · dividends reinvested · last 1yARWR +124.3% (+124.3%/yr)BRKRP +94.8% (+94.8%/yr)ARWR compounded faster over this window
ARWR BRKRP
ARWR vs BRKRP: by the numbers
- •BRKRP is the larger company ($8.77B vs $8.57B market cap).
- •Both run net losses; BRKRP's is the smaller (-2.03% vs -47.79% net margin).
- •ARWR grew revenue faster over the past five years (44.14% vs 9.10% CAGR).
- •BRKRP pays a dividend (3.35% yield), while ARWR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ARWR | BRKRP |
|---|---|---|
| Forward P/E | N/A | 206.08 |
| P/S ratio | 12.80 | 2.51 |
| P/B ratio | 18.41 | 3.66 |
| EV / EBITDA | N/A | 29.46 |
| FCF yield | N/A | 1.07% |
Profitability
| Metric | ARWR | BRKRP |
|---|---|---|
| Gross margin | 100.00% | 46.69% |
| Operating margin | 11.86% | 3.61% |
| Net margin | -47.79% | -2.03% |
| ROE | -68.73% | -2.97% |
| ROIC | -12.12% | 2.56% |
Dividends
| Metric | ARWR | BRKRP |
|---|---|---|
| Dividend yield | N/A | 3.35% |
Growth (annualized)
| Metric | ARWR | BRKRP |
|---|---|---|
| Revenue CAGR (5Y) | 44.14% | 9.10% |
| FCF CAGR (5Y) | N/A | -21.33% |
| Total return CAGR (5Y) | 0.75% | N/A |
Frequently asked
- Which has grown faster, ARWR or BRKRP?
- Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus BRKRP at 9.10%.
- Does ARWR or BRKRP pay a bigger dividend?
- BRKRP pays a dividend (3.35% yield), while ARWR has no payments in the available dividend history.
Go deeper
Dig into the metrics
Bruker dividend yieldArrowhead Pharmaceuticals ROEBruker ROEArrowhead Pharmaceuticals operating marginBruker operating marginArrowhead Pharmaceuticals revenue growthBruker revenue growthArrowhead Pharmaceuticals free cash flowBruker free cash flow
Arrowhead Pharmaceuticals & Bruker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.